Novavax' Nuvaxovid™ COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan for Use in Individuals Aged 18 and OverPRNewsWire • 06/23/22
Novavax stock surges after COVID-19 vaccine recommended for expanded CMA in the EU for 12-17 year oldsMarket Watch • 06/23/22
Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17PRNewsWire • 06/23/22
Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its DecisionBenzinga • 06/13/22
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and OverPRNewsWire • 06/13/22
5 Cutting-Edge Growth Stocks That Can Turn $200,000 Into $1 Million by 2030The Motley Fool • 06/12/22